1 エグゼクティブ・サマリー
2 序文
2.1 概要
2.2 ステークホルダー
2.3 調査範囲
2.4 調査方法
2.4.1 データマイニング
2.4.2 データ分析
2.4.3 データの検証
2.4.4 リサーチアプローチ
2.5 リサーチソース
2.5.1 一次調査ソース
2.5.2 セカンダリーリサーチソース
2.5.3 前提条件
3 市場動向分析
3.1 はじめに
3.2 推進要因
3.3 抑制要因
3.4 機会
3.5 脅威
3.6 製品分析
3.7 アプリケーション分析
3.8 エンドユーザー分析
3.9 新興市場
3.10 Covid-19の影響
4 ポーターズファイブフォース分析
4.1 供給者の交渉力
4.2 買い手の交渉力
4.3 代替品の脅威
4.4 新規参入の脅威
4.5 競争上のライバル関係
5 心室補助装置の世界市場（製品別
5.1 導入
5.2 左心室補助装置
5.3 右心室アシストデバイス
5.4 両心室アシストデバイス
5.5 全人工心臓
6 心室補助装置の世界市場：デザイン別
6.1 導入
6.2 植込み型心室補助装置
6.3 経皮的心室補助装置
7 心室補助装置の世界市場：流路タイプ別
7.1 はじめに
7.2 拍動流心室補助装置
7.3 連続流VAD
8 心室補助装置の世界市場：用途別
8.1 はじめに
8.2 ブリッジ・ツー・トランスプラント
8.3 目的地治療
8.4 回復への橋渡し
8.5 候補地への橋渡し
9 心室補助装置の世界市場：エンドユーザー別
9.1 導入
9.2 病院
9.3 心臓外科センター
9.4 在宅医療機関
9.5 その他のエンドユーザー
10 心室補助装置の世界市場：地域別
10.1 はじめに
10.2 北米
10.2.1 アメリカ
10.2.2 カナダ
10.2.3 メキシコ
10.3 ヨーロッパ
10.3.1 ドイツ
10.3.2 イギリス
10.3.3 イタリア
10.3.4 フランス
10.3.5 スペイン
10.3.6 その他のヨーロッパ
10.4 アジア太平洋
10.4.1 日本
10.4.2 中国
10.4.3 インド
10.4.4 オーストラリア
10.4.5 ニュージーランド
10.4.6 韓国
10.4.7 その他のアジア太平洋地域
10.5 南米
10.5.1 アルゼンチン
10.5.2 ブラジル
10.5.3 チリ
10.5.4 その他の南米地域
10.6 中東・アフリカ
10.6.1 サウジアラビア
10.6.2 アラブ首長国連邦
10.6.3 カタール
10.6.4 南アフリカ
10.6.5 その他の中東・アフリカ地域
11 主要開発
11.1 契約、パートナーシップ、提携、合弁事業
11.2 買収と合併
11.3 新製品上市
11.4 事業拡大
11.5 その他の主要戦略
12 企業プロファイリング
Abiomed Inc.
BiVACOR Inc
Abbott Laboratories
Berlin Heart GmbH
Calon Cardio
Medtronic PLC
SynCardia Systems LLC
Terumo Corporation
Jarvik Heart Inc.
ReliantHeart, Inc. and Sun Medical Technology Research Corp.
表一覧
表1 心室補助装置の世界市場展望：地域別（2022-2030年） ($MN)
表2 心室補助装置の世界市場展望：製品別（2022-2030年） ($MN)
表3 心室補助装置の世界市場展望：左心室アシストデバイス別 (2022-2030) ($MN)
表4 心室補助装置の世界市場展望：右心室アシストデバイス別 (2022-2030) ($MN)
表5 心室補助装置の世界市場展望：両心室アシストデバイス別 (2022-2030) ($MN)
表6 心室補助装置の世界市場展望：全人工心臓別 (2022-2030) ($MN)
表7 心室補助装置の世界市場展望：デザイン別 (2022-2030) ($MN)
表8 心室補助装置の世界市場展望：植込み型心室アシストデバイス別 (2022-2030) ($MN)
表9 心室補助装置の世界市場展望：経皮的心室アシストデバイス別 (2022-2030) ($MN)
表10 心室補助装置の世界市場展望：流れのタイプ別 (2022-2030) ($MN)
表11 心室補助装置の世界市場展望：拍動流VAD別 (2022-2030) ($MN)
表12 心室補助装置の世界市場展望：連続流VAD別 (2022-2030) ($MN)
表13 心室補助装置の世界市場展望：用途別 (2022-2030) ($MN)
表14 心室補助装置の世界市場展望：ブリッジ・ツー・トランスプラント別 (2022-2030) ($MN)
表15 心室補助装置の世界市場展望：目的地治療別 (2022-2030) ($MN)
表16 心室補助装置の世界市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表17 心室補助装置の世界市場展望：ブリッジツーキャンディダシー別 (2022-2030) ($MN)
表18 心室補助装置の世界市場展望：エンドユーザー別 (2022-2030) ($MN)
表19 心室補助装置の世界市場展望：病院別 (2022-2030) ($MN)
表20 心室補助装置の世界市場展望：心臓外科センター別 (2022-2030) ($MN)
表21 心室補助装置の世界市場展望：在宅介護機関別 (2022-2030) ($MN)
表22 心室補助装置の世界市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
表23 北米の心室補助装置の市場展望：国別 (2022-2030) ($MN)
表24 北米の心室補助装置市場展望：製品別 (2022-2030) ($MN)
表25 北米の心室補助装置市場展望：左心室補助装置別 (2022-2030) ($MN)
表26 北米の心室補助装置市場展望：右心室心室補助装置別 (2022-2030) ($MN)
表27 北米の心室補助装置市場展望：両心室補助装置別 (2022-2030) ($MN)
表28 北米の心室補助装置市場展望：全人工心臓別 (2022-2030) ($MN)
表29 北米の心室補助装置市場展望：デザイン別 (2022-2030) ($MN)
表30 北米の心室補助装置市場展望：植込み型心室補助装置別 (2022-2030) ($MN)
表31 北米の心室補助装置市場展望：経皮的心室補助装置別 (2022-2030) ($MN)
表32 北米の心室補助装置市場展望：流れのタイプ別 (2022-2030) ($MN)
表33 北米の心室補助装置市場展望：拍動流VAD別 (2022-2030) ($MN)
表34 北米の心室補助装置市場展望：連続流VAD別 (2022-2030) ($MN)
表35 北米の心室補助装置市場展望：用途別 (2022-2030) ($MN)
表36 北米の心室補助装置市場展望：ブリッジ・ツー・トランスプラント別 (2022-2030) ($MN)
表37 北米の心室補助装置市場展望：目的地治療別 (2022-2030) ($MN)
表38 北米の心室補助装置市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表39 北米の心室補助装置市場展望：ブリッジツーキャンディダシー別 (2022-2030) ($MN)
表40 北米の心室補助装置市場展望：エンドユーザー別 (2022-2030) ($MN)
表41 北米の心室補助装置市場展望：病院別 (2022-2030) ($MN)
表42 北米の心室補助装置市場展望：心臓手術センター別 (2022-2030) ($MN)
表43 北米の心室補助装置市場展望：在宅介護機関別 (2022-2030) ($MN)
表44 北米の心室補助装置市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
表45 ヨーロッパの心室補助装置市場展望：国別 (2022-2030) ($MN)
表46 ヨーロッパの心室補助装置市場展望：製品別 (2022-2030) ($MN)
表47 ヨーロッパの心室補助装置市場展望：左心室補助装置別 (2022-2030) ($MN)
表48 ヨーロッパの心室補助装置市場展望：右心室心室補助装置別 (2022-2030) ($MN)
表49 ヨーロッパの心室補助装置市場展望：両心室補助装置別 (2022-2030) ($MN)
表50 ヨーロッパの心室補助装置市場展望：全人工心臓別 (2022-2030) ($MN)
表51 ヨーロッパの心室補助装置市場展望：デザイン別 (2022-2030) ($MN)
表52 ヨーロッパの心室補助装置市場展望：植込み型心室補助装置別 (2022-2030) ($MN)
表53 ヨーロッパの心室補助装置市場展望：経皮的心室補助装置別 (2022-2030) ($MN)
表54 ヨーロッパの心室補助装置市場展望：流れのタイプ別 (2022-2030) ($MN)
表55 ヨーロッパの心室補助装置市場展望：拍動流VAD別 (2022-2030) ($MN)
表56 ヨーロッパの心室補助装置市場展望：連続流VAD別 (2022-2030) ($MN)
表57 ヨーロッパの心室補助装置市場展望：用途別 (2022-2030) ($MN)
表58 ヨーロッパの心室補助装置市場展望：ブリッジツートランスプラント別 (2022-2030) ($MN)
表59 ヨーロッパの心室補助装置市場展望：目的地治療別 (2022-2030) ($MN)
表60 ヨーロッパの心室補助装置市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表61 ヨーロッパの心室補助装置市場展望：ブリッジツー候補地別 (2022-2030) ($MN)
表62 ヨーロッパの心室補助装置市場展望：エンドユーザー別 (2022-2030) ($MN)
表63 ヨーロッパの心室補助装置市場展望：病院別 (2022-2030) ($MN)
表64 ヨーロッパの心室補助装置市場展望：心臓手術センター別 (2022-2030) ($MN)
表65 ヨーロッパの心室補助装置市場展望：在宅介護機関別 (2022-2030) ($MN)
表66 ヨーロッパの心室補助装置市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
表67 アジア太平洋地域の心室補助装置市場展望：国別 (2022-2030) ($MN)
表68 アジア太平洋地域の心室補助装置市場展望：製品別 (2022-2030) ($MN)
表69 アジア太平洋地域の心室補助装置市場展望：左心室補助装置別 (2022-2030) ($MN)
表70 アジア太平洋地域の心室補助装置市場展望：右心室補助装置別 (2022-2030) ($MN)
表71 アジア太平洋地域の心室補助装置市場展望：両心室補助装置別 (2022-2030) ($MN)
表72 アジア太平洋地域の心室補助装置市場展望：全人工心臓別 (2022-2030) ($MN)
表73 アジア太平洋地域の心室補助装置市場展望：デザイン別 (2022-2030) ($MN)
表74 アジア太平洋地域の心室補助装置市場展望：植込み型心室補助装置別 (2022-2030) ($MN)
表75 アジア太平洋地域の心室補助装置市場展望：経皮的心室補助装置別 (2022-2030) ($MN)
表76 アジア太平洋地域の心室補助装置市場展望：流れのタイプ別 (2022-2030) ($MN)
表77 アジア太平洋地域の心室補助装置市場展望：拍動流VAD別 (2022-2030) ($MN)
表78 アジア太平洋地域の心室補助装置市場展望：連続流VAD別 (2022-2030) ($MN)
表79 アジア太平洋地域の心室補助装置市場展望：用途別 (2022-2030) ($MN)
表80 アジア太平洋地域の心室補助装置市場展望：ブリッジツートランスプラント別 (2022-2030) ($MN)
表81 アジア太平洋地域の心室補助装置市場展望：目的地治療別 (2022-2030) ($MN)
表82 アジア太平洋地域の心室補助装置市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表83 アジア太平洋地域の心室補助装置市場展望：ブリッジツー候補地別 (2022-2030) ($MN)
表84 アジア太平洋地域の心室補助装置市場展望：エンドユーザー別 (2022-2030) ($MN)
表85 アジア太平洋地域の心室補助装置市場展望：病院別 (2022-2030) ($MN)
表86 アジア太平洋地域の心室補助装置市場展望：心臓手術センター別 (2022-2030) ($MN)
表87 アジア太平洋地域の心室補助装置市場展望：在宅介護機関別 (2022-2030) ($MN)
表88 アジア太平洋地域の心室補助装置市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
表89 南米の心室補助装置市場展望：国別 (2022-2030) ($MN)
表90 南米の心室補助装置市場展望：製品別 (2022-2030) ($MN)
表91 南米の心室補助装置市場展望：左心室補助装置別 (2022-2030) ($MN)
表92 南米の心室補助装置市場展望：右心室補助装置別 (2022-2030) ($MN)
表93 南米の心室補助装置市場展望：両心室補助装置別 (2022-2030) ($MN)
表94 南米の心室補助装置市場展望：全人工心臓別 (2022-2030) ($MN)
表95 南米の心室補助装置市場展望：デザイン別 (2022-2030) ($MN)
表96 南米の心室補助装置市場展望：植込み型心室補助装置別 (2022-2030) ($MN)
表97 南米の心室補助装置市場展望：経皮的心室補助装置別 (2022-2030) ($MN)
表98 南米の心室補助装置市場展望：流れのタイプ別 (2022-2030) ($MN)
表99 南米の心室補助装置市場展望：拍動流VAD別 (2022-2030) ($MN)
表100 南米の心室補助装置市場展望：連続流VAD別 (2022-2030) ($MN)
表101 南米の心室補助装置市場展望：用途別 (2022-2030) ($MN)
表102 南米の心室補助装置市場展望：ブリッジツートランスプラント別 (2022-2030) ($MN)
表103 南米の心室補助装置市場展望：目的地治療別 (2022-2030) ($MN)
表104 南米の心室補助装置市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表105 南米の心室補助装置市場展望：ブリッジツー候補地別 (2022-2030) ($MN)
表106 南米の心室補助装置市場展望：エンドユーザー別 (2022-2030) ($MN)
表107 南米の心室補助装置市場展望：病院別 (2022-2030) ($MN)
表108 南米の心室補助装置市場展望：心臓手術センター別 (2022-2030) ($MN)
表109 南米の心室補助装置市場展望：在宅介護機関別 (2022-2030) ($MN)
表110 南米の心室補助装置市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
表111 中東・アフリカの心室補助装置市場展望：国別 (2022-2030) ($MN)
表112 中東・アフリカの心室補助装置市場展望：製品別 (2022-2030) ($MN)
表113 中東・アフリカの心室補助装置市場展望：左心室補助装置別 (2022-2030) ($MN)
表114 中東・アフリカの心室補助装置市場展望：右心室補助装置別 (2022-2030) ($MN)
表115 中東・アフリカの心室補助装置市場展望：両心室補助装置別 (2022-2030) ($MN)
表116 中東・アフリカの心室補助装置市場展望：全人工心臓別 (2022-2030) ($MN)
表117 中東・アフリカの心室補助装置市場展望：デザイン別 (2022-2030) ($MN)
表118 中東・アフリカの心室補助装置市場展望：植込み型心室補助装置別 (2022-2030) ($MN)
表119 中東・アフリカの心室補助装置市場展望：経皮的心室補助装置別 (2022-2030) ($MN)
表120 中東・アフリカの心室補助装置市場展望：流れのタイプ別 (2022-2030) ($MN)
表121 中東・アフリカの心室補助装置市場展望：拍動流VAD別 (2022-2030) ($MN)
表122 中東・アフリカの心室補助装置市場展望：連続流VAD別 (2022-2030) ($MN)
表123 中東・アフリカの心室補助装置市場展望：用途別 (2022-2030) ($MN)
表124 中東・アフリカの心室補助装置市場展望：ブリッジツートランスプラント別 (2022-2030) ($MN)
表125 中東・アフリカの心室補助装置市場展望：目的地治療別 (2022-2030) ($MN)
表126 中東・アフリカの心室補助装置市場展望：回復への橋渡し療法別 (2022-2030) ($MN)
表127 中東・アフリカの心室補助装置市場展望：ブリッジツー候補地別 (2022-2030) ($MN)
表128 中東・アフリカの心室補助装置市場展望：エンドユーザー別 (2022-2030) ($MN)
表129 中東・アフリカの心室補助装置市場展望：病院別 (2022-2030) ($MN)
表130 中東・アフリカの心室補助装置市場展望：心臓手術センター別 (2022-2030) ($MN)
表131 中東・アフリカの心室補助装置市場展望：在宅介護機関別 (2022-2030) ($MN)
表132 中東・アフリカの心室補助装置市場展望：その他のエンドユーザー別 (2022-2030) ($MN)
According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.
Market Dynamics:
Driver:
Global prevalence of heart failure
In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.
Restraint:
Risks associated with implantation
Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.
Opportunity:
Continuous innovations in VAD technology
Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.
Threat:
Inadequate reimbursement policies and insurance coverage
VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.
Covid-19 Impact:
The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.
The biventricular assist devices segment is expected to be the largest during the forecast period
The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.
Region with largest share:
North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.
Region with highest CAGR:
Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.
Key players in the market
Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .
Key Developments:
In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.
In September 2024, Abbott announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.
In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.
Products Covered:
• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Biventricular Assist Device
• Total Artificial Heart
Designs Covered:
• Implantable Ventricular Assist Devices
• Transcutaneous Ventricular Assist Devices
Type of Flows Covered:
• Pulsatile Flow VAD
• Continuous Flow VAD
Applications Covered:
• Bridge-to-Transplant
• Destination Therapy
• Bridge-to-Recovery
• Bridge-to-Candidacy
End Users Covered:
• Hospitals
• Cardiac Surgery Centers
• Home Care Agencies
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Ventricular Assist Devices Market, By Product
5.1 Introduction
5.2 Left Ventricular Assist Device
5.3 Right Ventricular Assist Device
5.4 Biventricular Assist Device
5.5 Total Artificial Heart
6 Global Ventricular Assist Devices Market, By Design
6.1 Introduction
6.2 Implantable Ventricular Assist Devices
6.3 Transcutaneous Ventricular Assist Devices
7 Global Ventricular Assist Devices Market, By Type of Flow
7.1 Introduction
7.2 Pulsatile Flow VAD
7.3 Continuous Flow VAD
8 Global Ventricular Assist Devices Market, By Application
8.1 Introduction
8.2 Bridge-to-Transplant
8.3 Destination Therapy
8.4 Bridge-to-Recovery
8.5 Bridge-to-Candidacy
9 Global Ventricular Assist Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Cardiac Surgery Centers
9.4 Home Care Agencies
9.5 Other End Users
10 Global Ventricular Assist Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abiomed Inc.
12.2 BiVACOR Inc.
12.3 Abbott Laboratories
12.4 Berlin Heart GmbH
12.5 Calon Cardio
12.6 Medtronic PLC
12.7 SynCardia Systems LLC
12.8 Terumo Corporation
12.9 Jarvik Heart Inc.
12.10 ReliantHeart, Inc.
12.11 Sun Medical Technology Research Corp
List of Tables
Table 1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Table 111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
Table 112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
Table 113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
Table 114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
Table 115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
Table 116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
Table 117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
Table 118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
Table 119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
Table 120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
Table 121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
Table 122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
Table 123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
Table 124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
Table 125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
Table 126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
Table 127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
Table 128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
Table 129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
Table 130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
Table 131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
Table 132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
